Hakea saligna
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Hakea saligna |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Hakea Saligna |
| Ipni Id | NPO14394 |
| Plant Name | Hakea Saligna |
| Genus Tax Id | 54940 |
| Disease Name | Solid tumour/cancer, Glaucoma, Breast cancer, Idiopathic interstitial pneumonitis, Adrenomedullary hyperfunction, Fungal infection, Acute myeloid leukaemia, Malignant haematopoietic neoplasm, Mature T-cell lymphoma, Transplanted organ/tissue, Rheumatoid arthritis, Pain, unspecified, Chronic kidney disease, Schizophrenia, Diabetes mellitus, type unspecified, Chronic arterial occlusive disease, Inborn lipid metabolism error, Osteosarcoma, Acute diabete complication, Myotonic disorder, Peroxisomal disease, Colorectal cancer, Alzheimer disease, BCR-ABL1-negative chronic myeloid leukaemia, Acute/subacute hepatic failure, Hyperlipidemia, Skin and skin-structure infection, Seborrhoeic dermatitis, Pulmonary hypertension, Myasthenia gravis, Psoriasis, Bacterial infection, Encephalopathy, Mature B-cell lymphoma, Liver cancer, Autoimmune disease, Lupus erythematosus, Irritable bowel syndrome, Influenza, Gout, Asthma, Parkinsonism, Neuropathy, Inborn purine/pyrimidine/nucleotide metabolism error, Mastocytosis, Coronavirus infection, Heart failure, Type 2 diabetes mellitus, Crohn disease, Hyper-lipoproteinaemia, Chronic pain, Fragile X chromosome, Psychotic disorder, Obesity, Metabolic disorder, Lung cancer, Diffuse large B-cell lymphoma, Choreiform disorder, Phakomatoses/hamartoneoplastic syndrome, Renal cell carcinoma, Thrombosis, Allergic/hypersensitivity disorder, Multiple myeloma, Cocaine use disorder, Cataract, Myeloproliferative neoplasm, Abortion, Multiple sclerosis, Dyslipidemia, Bone/articular cartilage neoplasm, Cardiovascular disease, Muscular dystrophy, Autism spectrum disorder, Human immunodeficiency virus disease, Chronic myelomonocytic leukaemia, Non-alcoholic fatty liver disease, Peritoneal cancer, Dementia, Atopic eczema, Tic disorder, Ovarian cancer, Inflammatory arthropathy, Mineral deficiency, Indeterminate colitis, Myocardial infarction, Unspecified viral infection of unspecified site, Brain cancer, Synthesis disorder, Nephritic syndrome, Dysplastic naevus, Melanoma, Primary sclerosing cholangitis, Congenital cytomegalovirus infection, Glioma, malignant, Prostate cancer, Spinal pain, Vasomotor/allergic rhinitis, Carcinosarcoma of uterus, Coeliac disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Inflammatory bowel diseases, unspecified, Osteoarthritis, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Hepatoblastoma, Leishmaniasis, Idiopathic pulmonary fibrosis, Adenocarcinoma of stomach, Atrial fibrillation, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Myotonic dystrophy, Other specified malignant neoplasms of kidney, except renal pelvis, Malignant neoplasms of bladder, Keratoconus, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Pre-eclampsia, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Melanoma of skin, Pneumonia due to Pseudomonasaeruginosa, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Systemic sclerosis, Adenocarcinoma of prostate, Chronic rhinosinusitis, Systemic lupus erythematosus, Malignant neoplasms of thyroid gland, unspecified, Malignant neoplasms of stomach, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Polycystic ovary syndrome, Malignant neoplasms of thymus, Invasive carcinoma of breast, Heart failure, unspecified, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Germ cell tumour of testis, Carpal tunnel syndrome, Malignant neoplasms of adrenal gland, Malignant neoplasm of pancreas, Gliomas of brain |
| Genus Name | Hakea |
| Disease Id | 2A00-2F9Z, 9C61, 2C60-2C6Y, CB03, 5A75, 1F29-1F2F, 2A60, 2B33, 2A90, QB63, FA20, MG3Z, GB61, 6A20, 5A14, BD4Z, 5C52, 2B51, 5A2Y, 8C71, 5C57, 2B91, 8A20, 2A41, DB91, 5C80, 1F28-1G0Z, EA81, BB01, 8C6Y, EA90, 1A00-1C4Z, 8.00E+47, 2A85, 2C12, 4A40-4A45, 4A40, DD91, 1E30-1E32, FA25, CA23, 8A00, 8C0Z, 5C55, 2A21, 1D92, BD10-BD1Z, 5A11, DD70, MG30, LD55, 6A20-6A25, 5B80-5B81, 5C50-5D2Z, 2C25, 2A81, 8A01, LD2D, 2C90, DB61-GB90, 4A80-4A8Z, 2A83, 6C45, 9B10, 2A20, JA00, 8A40, 5C80-5C81, 2F7B, BA00-BE2Z, 8C70, 6A02, 1C60-1C62, 2A40, DB92, 2C51, 6D80-6D8Z, EA80, 8A05, 2C73, FA2Z, 5B5K, DD72, BA41-BA43, 1D9Z, 2A00, 5C52-5C59, GB40, XH9035, 2C30, DB96.2, KA62.3, XH4RQ3, 2C82, ME84, CA08, 2C76.43, DA95, 2C73.4, XH3854, DD7Z, FA0Z, 2C15, 2C12.01, 1F54, CB03.4, 2B72.0, BC81.3, 2D60.0, 8C71.0, 2C90.Y, 2C94, 9A78.50, 2C25.2, 1D46, 2C10.0, 2C26.0, JA24, LA88.2, 2B90.Y, CA40.05, 2C12.02, 2C25.Y, GA10.B4, 2B70, 2C94.2, 1D82, 4A42, 2C82.0, CA0A, 4A40.0, 2D10.Z, 2B72, 2C25.0, 2C76.Z, 1D40, 5A80.1, 2C27, 2C61, BD1Z, 1C62, 2A00.00, XH6153, 2C80.2, 8C10.0, 2D11, 2C10, 2A00.0 |
| Family Name | Proteaceae |
| Family Tax Id | 4328 |
- 1. ((1r,4as,5r,7ar)-5-Hydroxy-1-((2s,3r,4s,5s,6r)-3,4,5-Trihydroxy-6-(Hydroxymethyl)tetrahydro-2h-Pyran-2-Yloxy)-1,4a,5,7a-Tetrahydrocyclopenta[C]pyran-7-Yl)methyl 4-Hydroxybenzoate (PubChem CID: 51346123)
- 2. (+)-Alpha-Terpineol (PubChem CID: 442501)
- 3. (2e)-2-[(4as,5r,7r,8r,8as)-5-Acetyloxy-4,4,7,8a-Tetramethylspiro[2,3,4a,5,6,7-Hexahydro-1h-Naphthalene-8,5'-Oxolane]-2'-Ylidene]acetic Acid (PubChem CID: 101357917)
- 4. (2r,3r,4s,5s,6r)-2-[[(3s,8s,9s,10s,13r,14s,17r)-17-[(2r,5r)-5-Ethyl-6-Methylheptan-2-Yl]-10-Hydroxy-13-Methyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Yl]oxy]-6-(Hydroxymethyl)oxane-3,4,5-Triol (PubChem CID: 162860929)
- 5. (2s,3s,4r)-4-[(3s)-3-Hydroxy-3-Methylpent-4-Enyl]-3,4,8,8-Tetramethyl-2,3,6,7-Tetrahydronaphthalen-2-Ol (PubChem CID: 163049119)
- 6. (2s,4ar,6ar,6br,8ar,12ar,14as,14br)-2,4a,6b,9,9,12a,14a-Heptamethyl-10-Oxo-3,4,5,6a,7,8,8a,11,12,13,14,14b-Dodecahydro-1h-Picene-2-Carbaldehyde (PubChem CID: 162870678)
- 7. (2s,4as,10ar)-1,1,4a-Trimethyl-7-Propan-2-Yl-2,3,4,9,10,10a-Hexahydrophenanthren-2-Ol (PubChem CID: 13996029)
- 8. (3r,4r)-4-[(3s)-3-Hydroxy-3-Methylpent-4-Enyl]-3,4,8,8-Tetramethyl-3,5,6,7-Tetrahydro-2h-Naphthalen-1-One (PubChem CID: 162852129)
- 9. (3r,4r,4as,8as)-4-[2-(Furan-3-Yl)ethyl]-4-Hydroxy-3,4a,8,8-Tetramethyl-2,3,5,6,7,8a-Hexahydronaphthalen-1-One (PubChem CID: 101717490)
- 10. (3s,4s)-4-[Bis(7-Methoxy-1,3-Benzodioxol-5-Yl)methyl]-3-Methyloxolan-2-One (PubChem CID: 11486787)
- 11. (3s,8s,9s,10s,13r,14s,17r)-17-[(2r,5r)-5-Ethyl-6-Methylheptan-2-Yl]-13-Methyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthrene-3,10-Diol (PubChem CID: 162862239)
- 12. (4ar,16as)-3,4,4a,5,16a,17,18,19-Octahydro-21,22,26-Trimethoxy-4,17-Dimethyl-2h-1,24:12,15-Dietheno-6,10-Metheno-16h-Pyrido(2',3':17,18)(1,10)dioxacycloeicosino(2,3,4-Ij)isoquinolin-9-Ol (PubChem CID: 442333)
- 13. (4as,7r,8r,8as)-4,4,7,8a-Tetramethylspiro[2,3,4a,5,6,7-Hexahydro-1h-Naphthalene-8,5'-Oxolane]-2'-One (PubChem CID: 15559824)
- 14. (E)-N-[(2s,3s,4r,8r,9s,10r,13r,17s)-17-[(1s)-1-(Dimethylamino)ethyl]-2,4-Dihydroxy-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Yl]-2-Methylbut-2-Enamide (PubChem CID: 44358199)
- 15. (E)-N-[(3s,4r,8s,9s,10r,13s,14s,17s)-17-[(1s)-1-(Dimethylamino)ethyl]-4-Hydroxy-10,13-Dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Yl]-2-Methylbut-2-Enamide (PubChem CID: 11154961)
- 16. (E)-N-[(3s,8s,9s,10r,13s,14s,17s)-17-[(1s)-1-(Dimethylamino)ethyl]-10,13-Dimethyl-4-Oxo-1,2,3,7,8,9,11,12,14,15,16,17-Dodecahydrocyclopenta[A]phenanthren-3-Yl]-2-Methylbut-2-Enamide (PubChem CID: 44358068)
- 17. 2,3-Dihydroxybenzoic Acid (PubChem CID: 19)
- 18. 3-[2-[(1r,2r,4as,8as)-1-Hydroxy-2,5,5,8a-Tetramethyl-3,4,4a,6,7,8-Hexahydro-2h-Naphthalen-1-Yl]ethyl]-2h-Furan-5-One (PubChem CID: 102105798)
- 19. 3-Methoxysalicylic Acid (PubChem CID: 70140)
- 20. 3alpha-Hydroxyurs-12-En-28-Oic Acid (PubChem CID: 7163177)
- 21. 5,7-Dihydroxy-3,6,3',4'-Tetramethoxyflavone (PubChem CID: 5379563)
- 22. 6'-(P-Hydroxybenzoyl)mussaenosidic Acid, >=95% (Lc/ms-Elsd) (PubChem CID: 23955877)
- 23. [(1r,2s,4as,8as)-2-Acetyloxy-4-[(3s)-3-Hydroxy-3-Methylpent-4-Enyl]-3,4a,8,8-Tetramethyl-1,2,5,6,7,8a-Hexahydronaphthalen-1-Yl] Acetate (PubChem CID: 162997046)
- 24. [(1r,3r,4r,4as,8as)-4-Hydroxy-3,4a,8,8-Tetramethyl-4-[2-(5-Oxo-2h-Furan-4-Yl)ethyl]-2,3,5,6,7,8a-Hexahydro-1h-Naphthalen-1-Yl] Acetate (PubChem CID: 10022565)
- 25. [(1s,2r,3s,4r)-1-Acetyloxy-4-[(3s)-3-Hydroxy-3-Methylpent-4-Enyl]-3,4,8,8-Tetramethyl-1,2,3,5,6,7-Hexahydronaphthalen-2-Yl] Acetate (PubChem CID: 38363004)
- 26. [(1s,2r,3s,4r)-2-Hydroxy-4-[(3s)-3-Hydroxy-3-Methylpent-4-Enyl]-3,4,8,8-Tetramethyl-1,2,3,5,6,7-Hexahydronaphthalen-1-Yl] Acetate (PubChem CID: 163047906)
- 27. Alpha-Alectoronic Acid (PubChem CID: 15558610)
- 28. Alpha-Amyrin (PubChem CID: 73170)
- 29. Alpha-Terpinyl Acetate, (-)- (PubChem CID: 93317)
- 30. Artemetin (PubChem CID: 5320351)
- 31. Atranorin (PubChem CID: 68066)
- 32. Behenic Acid (PubChem CID: 8215)
- 33. Beta-Sitosterol (PubChem CID: 222284)
- 34. Betulinic Acid (PubChem CID: 64971)
- 35. Caryophyllene (PubChem CID: 5281515)
- 36. Casticin (PubChem CID: 5315263)
- 37. Chrysoplenol D (PubChem CID: 5280699)
- 38. Corosolic Acid (PubChem CID: 6918774)
- 39. Gamma-Tocopherol (PubChem CID: 92729)
- 40. Hexacosanoic Acid (PubChem CID: 10469)
- 41. Humulene (PubChem CID: 5281520)
- 42. Lignoceric Acid (PubChem CID: 11197)
- 43. Lupeol (PubChem CID: 259846)
- 44. Luteolin (PubChem CID: 5280445)
- 45. Mussaenosidic Acid (PubChem CID: 21633105)
- 46. Myristic Acid (PubChem CID: 11005)
- 47. N-((3s,5s,8r,9s,10s,13s,14s,17s)-17-((S)-1-Dimethylamino-Ethyl)-10,13-Dimethyl-Hexadecahydro-Cyclopenta(A)phenanthren-3-Yl)-Acetamide (PubChem CID: 44358179)
- 48. N-[(1s)-1-[(3s,5s,8r,9s,10s,13s,14s,17s)-10,13-Dimethyl-3-(Methylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1h-Cyclopenta[A]phenanthren-17-Yl]ethyl]-N-Methylacetamide (PubChem CID: 44364863)
- 49. N-[(3s,5s,8r,9s,10s,13s,14s,17s)-17-[(1s)-1-(Dimethylamino)ethyl]-10,13-Dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-Tetradecahydro-1h-Cyclopenta[A]phenanthren-3-Yl]-N-Methylbenzamide (PubChem CID: 10004669)
- 50. Negundoside (PubChem CID: 9935561)
- 51. Oleic Acid (PubChem CID: 445639)
- 52. P-Anisic Acid (PubChem CID: 7478)
- 53. Palmitoleic Acid (PubChem CID: 445638)
- 54. Previtexilactone (PubChem CID: 21636179)
- 55. Rotundifuran (PubChem CID: 9841926)
- 56. Sitogluside (PubChem CID: 5742590)
- 57. Stearic Acid (PubChem CID: 5281)
- 58. Taraxerone (PubChem CID: 92785)
- 59. Ursolic Acid (PubChem CID: 64945)
- 60. Vanillin (PubChem CID: 1183)
- 61. Vitetrifolin B (PubChem CID: 15543011)
- 62. Vitetrifolin C (PubChem CID: 15543012)
- 63. Vitex Norditerpenoid 1 (PubChem CID: 11208535)
- 64. Vitex Norditerpenoid 2 (PubChem CID: 11462191)
- 65. Vitexilactone (PubChem CID: 21636178)
- 66. Vitexin (PubChem CID: 5280441)
- 1. Alzheimer's Disease 1
- 2. Arthritis
- 3. Arthritis, Gouty
- 4. Arthritis, Rheumatoid
- 5. Asthma
- 6. Cardiovascular Diseases
- 7. Cataract
- 8. Celiac Disease
- 9. Cholera
- 10. Crohn Disease
- 11. Dementia
- 12. Diabetes Mellitus
- 13. Glaucoma
- 14. Inflammatory Bowel Diseases
- 15. Influenza, Human
- 16. Liver Neoplasms
- 17. Lupus Erythematosus, Systemic
- 18. Muscular Dystrophies
- 19. Myocardial Infarction
- 20. Nephritis
- 21. Obesity
- 22. Osteoarthritis
- 23. Pre-Eclampsia
- 24. Psoriasis
- 25. Psychotic Disorder
- 26. Scleroderma, Systemic
Not listed in any formulations.